Are you Dr. Polizzotto?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bldg 10 RM 6n110
National Institutes of Health 9000 Rockville Pike
Bethesda, MD 20892Phone+1 301-402-1541Fax+1 301-480-5955
Clinical Trials
- Body Composition Sub-study of the D2EFT Trial Start of enrollment: 2019 Dec 05
- Inflammation and Co-Infections in D²EFT Start of enrollment: 2021 Feb 01
Publications & Presentations
PubMed
- 77 citationsViral, immunologic, and clinical features of primary effusion lymphoma.Kathryn Lurain, Mark N. Polizzotto, Karen Aleman, Manisha Bhutani, Kathleen M. Wyvill
Blood. 2019-04-18 - 128 citationsClinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammator...Mark N. Polizzotto, Thomas S. Uldrick, Kathleen M. Wyvill, Karen Aleman, Vickie Marshall
Clinical Infectious Diseases. 2016-03-15 - 69 citationsBisphosphonate-associated osteonecrosis of the auditory canal.Mark N. Polizzotto, Vincent C. Cousins, Anthony P. Schwarer
British Journal of Haematology. 2006-01-01
Press Mentions
COVID Booster: Mixing and Matching Boosters, Delayed Surgery, and Testing Recalcitrant ChildrenJanuary 29th, 2022- IV Hyperimmune Immunoglobulin No Help in Severe COVIDJanuary 28th, 2022
- International Trial Uncovers Crucial Gaps in Our Understanding of Influenza TherapiesNovember 27th, 2020
- Join now to see all
